Loading…
Bon Natural Life Limited is projected to decline to $1.15 by 2027, a -6% move from its current price of $1.22. BON is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.19 | $1.22 | $1.25 | +0.03% |
| Jul 13 | $1.18 | $1.22 | $1.27 | +0.06% |
| Jul 14 | $1.17 | $1.22 | $1.28 | +0.09% |
| Jul 15 | $1.16 | $1.22 | $1.29 | +0.12% |
| Jul 16 | $1.15 | $1.22 | $1.30 | +0.16% |
| Jul 17 | $1.14 | $1.22 | $1.31 | +0.19% |
| Jul 18 | $1.14 | $1.22 | $1.31 | +0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.14 | $1.22 | $1.31 | +0.22% |
| Week 2 | $1.11 | $1.23 | $1.35 | +0.44% |
| Week 3 | $1.09 | $1.23 | $1.39 | +0.65% |
| Week 4 | $1.07 | $1.23 | $1.42 | +0.87% |
| Week 5 | $1.05 | $1.23 | $1.45 | +1.09% |
| Week 6 | $1.04 | $1.24 | $1.47 | +1.31% |
| Week 7 | $1.03 | $1.24 | $1.49 | +1.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants.
The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries.
Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China. It operates across the People's Republic of China, Europe, North America, and the Middle East.
BON trades at $1.21 per share with a market capitalization of $12.31M and ranks 4795.
The near-term outlook is mixed with a neutral stance for 2026: min $1.13, avg $1.21, max $1.63, ROI 0, sentiment NEUTRAL.
From 2027 through 2030 the forecast remains NEUTRAL with 2027 min $0.884, avg $1.13, max $1.54, ROI -6.4; 2028 min $0.875, avg $1.16, max $1.65, ROI -4.2; 2029 min $0.8358, avg $1.14, max $1.68, ROI -5.9; 2030 min $0.842, avg $1.18, max $1.78, ROI -2.8.
Starting 2031 the forecast turns BULLISH with higher averages, including 2031 avg $1.46; 2032 avg $1.47; 2033 avg $1.50; 2034 avg $1.56; 2035 avg $1.33; and long-run gains with 2040 avg $2.04 and 2050 avg $3.13.
A major floor 24.0% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 21.3% above — a clean break opens room to run.
A major ceiling 33.3% above — clearing it would confirm fresh momentum.
Key BON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.20 | Buy | $1.20 | Buy |
| MA 10 | $1.19 | Buy | $1.20 | Buy |
| MA 20 | $1.22 | Sell | $1.22 | Buy |
| MA 50 | $1.25 | Sell | $1.26 | Sell |
| MA 100 | $1.34 | Sell | $1.39 | Sell |
| MA 200 | $1.57 | Sell | $3.30 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.88 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -6.49 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.83 | Buy |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.27 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 55.75 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 1.20 | Buy |
| ADX (14) | 13.60 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture shows bearish sentiment. RSI14 is 50. The 50-day simple moving average sits at $1.27, while the 200-day simple moving average sits at $1.60. Support is at $1.13 and resistance at $1.48. The 30-day price range spans $0.9758 to $1.50, and annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.13 | $1.22 | $1.62 | 0% | Neutral | |
| $0.9175 | $1.15 | $1.53 | -6% | Neutral | |
| $0.9226 | $1.19 | $1.64 | -3% | Neutral | |
| $0.8972 | $1.18 | $1.67 | -3% | Neutral | |
| $0.8939 | $1.20 | $1.74 | -1% | Neutral | |
| $1.07 | $1.46 | $2.16 | +20% | Neutral | |
| $1.06 | $1.48 | $2.23 | +21% | Bullish | |
| $1.06 | $1.50 | $2.30 | +23% | Bullish | |
| $1.10 | $1.58 | $2.46 | +29% | Bullish | |
| $0.9676 | $1.41 | $2.23 | +16% | Neutral | |
| $1.32 | $2.05 | $3.44 | +68% | Bullish | |
| $1.86 | $3.24 | $5.95 | +166% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.13 | $1.22 | $1.49 | +0.00% |
| August 2026 | $1.07 | $1.27 | $1.53 | +3.83% |
| September 2026 | $1.06 | $1.26 | $1.54 | -0.92% |
| October 2026 | $1.08 | $1.29 | $1.59 | +2.66% |
| November 2026 | $1.10 | $1.32 | $1.65 | +2.53% |
| December 2026 | $1.07 | $1.29 | $1.62 | -2.37% |
Click any year to see its month-by-month BON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BON is projected to trade between $1.13 and $1.62, averaging $1.22 — a potential gain of 0% from today's $1.22. Price action looks broadly range-bound.
Bon Natural Life Limited's 2027 outlook centres on $1.15, within a $0.9175 to $1.53 range. That is -6% versus the projected 2026 average. That marks a -6% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, BON could reach as high as $1.64, with a base case around $1.19 and support toward $0.9226 — roughly -3% from $1.22. Price action looks broadly range-bound.
Expect BON to range from $0.8972 to $1.67 through 2029. The $1.18 average target implies a -3% move from current prices. That is -1% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The BON price prediction for 2030 points to an average of $1.20 (low $0.8939, high $1.74) — a potential decline of -1% on today's $1.22. Price action looks broadly range-bound.
In 2031, BON is projected to trade between $1.07 and $2.16, averaging $1.46 — a potential gain of +20% from today's $1.22. That is up +21% on the projected 2030 average. A consolidation phase looks the most probable path here.
Bon Natural Life Limited's 2032 outlook centres on $1.48, within a $1.06 to $2.23 range. That is up +1% on the projected 2031 average. That marks a +21% change versus current levels. Momentum favours further upside here.
By 2033, BON could reach as high as $2.30, with a base case around $1.50 and support toward $1.06 — roughly +23% from $1.22. Buyers look set to stay in control over this stretch.
Expect BON to range from $1.10 to $2.46 through 2034. The $1.58 average target implies a +29% move from current prices. That is up +5% on the projected 2033 average. Momentum favours further upside here.
The BON price prediction for 2035 points to an average of $1.41 (low $0.9676, high $2.23) — a potential gain of +16% on today's $1.22. A consolidation phase looks the most probable path here.
In 2040, BON is projected to trade between $1.32 and $3.44, averaging $2.05 — a potential gain of +68% from today's $1.22. That is up +45% on the projected 2035 average. Momentum favours further upside here.
Bon Natural Life Limited's 2050 outlook centres on $3.24, within a $1.86 to $5.95 range. That is up +58% on the projected 2040 average. That marks a +166% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in BON today (≈ 819.672131 BON) could be worth
$2,655.35
+$1,655.35 (+166%) by 2050 · US Dollar
Based on the average projected BON price of $3.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BONwould be worth at today's price.
$1,000 invested in BON on Jul 10, 2025 (≈ 653.594783 BON) would be worth
$797.39
-$202.61 (-20.3%) today · 0.80× · US Dollar
Based on a BON entry price of $1.53 vs. today's $1.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.18 | $1,034.78 | +3.5% |
| 1 month ago | $1.47 | $829.93 | -17.0% |
| 3 months ago | $1.31 | $931.3 | -6.9% |
| 6 months ago | $1.7 | $717.65 | -28.2% |
| 1 year ago | $1.53 | $797.39 | -20.3% |
| All time (5.0y) ago | $2,300 | $0.53 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BON forecast.
Our base-case forecast reaches $2.40 around 2050.
Implied market cap at $2.40: $14.61M
The multi-year forecast indicates a shift to bullish sentiment beginning 2031, with 2031 average price $1.46 and max $2.26, offering a 20.5 upside potential. The path continues higher in 2032 (avg $1.47; max $2.33; ROI 21.4) and 2033 (avg $1.50; max $2.42; ROI 24). In 2034 the average rises to $1.56 with a max of $2.56 and ROI 28.7, while 2035 shows a softer range (avg $1.33; max $2.23; ROI 10.2).
By 2040 the forecast envisions an average price of $2.04 and a max of $3.66 with ROI 68.5, and by 2050 an average of $3.13 and a max of $6.21 with ROI 158.7. These are estimates and not guarantees; real outcomes will depend on market conditions and other factors.
Tap a question to reveal the answer.
2030 min $0.842; avg $1.18; max $1.78; ROI -2.8; sentiment NEUTRAL.
2040 min $1.21; avg $2.04; max $3.66; ROI 68.5; sentiment BULLISH.
The forecast shows 2026 min $1.13; avg $1.21; max $1.63; ROI 0; sentiment NEUTRAL, with bullish sentiment in 2031–2050 and ROI up to 158.7% by 2050.
2031 avg $1.46; 2032 avg $1.47; 2033 avg $1.50; 2034 avg $1.56; 2040 avg $2.04; 2050 avg $3.13; ROI 20.5, 21.4, 24, 28.7, 68.5, 158.7; sentiment BULLISH in later years.
Current price $1.21; market capitalization $12.31M; rank 4795.
Bon Natural Life Limited Community Discussion
0Share your Bon Natural Life Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.